en fr

Publications in peer-reviewed journals

A.International publications in peer-reviewed journals

  1. Grynberg M, O. Graesslin, J. Teyssedre, C. Quereux, D. Gaillard, F. Carré-Pigeon.Prenatal diagnosis in monozygotic twins with Down’s syndrome who had different phenotypes. Prenatal diagnosis, 2007;27(6):552-4.
  2. Grynberg M., Teyssedre J, Andre C, Graesslin O. Rupture of Ectopic Pregnancy With negative Serum beta-hCG Leading to Hemorrhagic Shock. Obstet Gynecol. 2009;113(2 Pt 2):537-9.
  3.  Grynberg M., Teyssedre J., Staerman F. Gluteo-vaginal fistula after posterior intravaginal slingplasty: a case report. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(7):877-9.
  4. Grynberg , Feyereisen E., Scheffer J.B., Koutroubis P., Frydman R., Fanchin R. Early follicle development alters the relationship between antral follicle counts and inhibin B and FSH levels on cycle day 3 Feril Steril, 2010;93(3):894-9.
  5. Grynberg M, Genro V, Gallot V, El-Ali A, Frydman R, Fanchin R. Early follicle development during the luteal-follicular transition affects the predictability of serum follicle stimulating hormone but not antimüllerian hormone levels on cycle day 3. Fertil Steril. 2010;94(5):1827-31.
  6. Grynberg M, Fanchin R, Dubost G, Colau JC, Brémont-Weil C, Frydman R, Ayoubi JM. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online. 2010;20(4):553-8.
  7. Young J, Bouligand J, Francou B, Raffin-Sanson ML, Gaillez S, Jeanpierre M, Grynberg M, Kamenicky P, Chanson P, Brailly-Tabard S, Guiochon-Mantel A. TAC3 and TACR3 Defects Cause Hypothalamic Congenital Hypogonadotropic Hypogonadism in Humans. J Clin Endocrinol Metab. 2010;95(5):2287-95.
  8. Pidoux G, Gerbaud P, Gnidehou S, Grynberg M, Geneau G, Guibourdenche J, Carette D, Cronier L, Evain-Brion D, Malassine A, Frendo JL. ZO-1 is involved in trophoblastic cells differentiation in human placenta. Am J Physiol Cell Physiol. 2010;298(6):C1517-26.
  9. Lamazou F, Arbo E, Salama S, Grynberg M, Frydman R, Fanchin R. Reliability of automated volumetric measurement of multiple growing follicles in controlled ovarian hyperstimulation. Fertil Steril. 2010;94(6):2172-6.
  10. Grynberg M, Salenave S, Young J, Chanson P. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010;95(10):4518-25.
  11. Genro VK, Grynberg M, Scheffer JB, Roux I, Frydman R, Fanchin R. Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Hum Reprod. 2011;26(3):671-7
  12. Roux I, Grynberg M, Linehan J, Messner A, Deffieux X. Ovarian cryopreservation after laparoscopic ovariectomy using the Endo-GIA stapling device and LAPRO-clip absorbable ligating clip in a woman: a case report. J Med Case Reports. 2011;5(1):48
  13. Taieb J, Grynberg M, Pierre A, Arouche N, Massart P, Belville C, Hesters L, Frydman R, Catteau-Jonard S, Fanchin R, Picard JY, Josso N, Rey RA, di Clemente N. FSH and Its Second Messenger cAMP Stimulate the Transcription of Human Anti-Mullerian Hormone in Cultured Granulosa Cells. Mol Endocrinol. 2011;25(4):645-55.
  14. Grynberg M, Ayoubi JM, Bulletti C, Frydman R, Fanchin R. Uterine transplantation: a promising surrogate to surrogacy? Ann N Y Acad Sci. 2011;1221(1):47-53.
  15. Grynberg M, Berwanger AL, Toledano M, Frydman R, Deffieux X, Fanchin R. Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected in women presenting with severe ovarian hyperstimulation syndrome. Fertil Steril. 2011;96(4):869-71.
  16. Treves R, Grynberg M, Hesters L, Frydman R. Fertility preservation in women with cancer: importance of a multidisciplinary approach. Womens Health (Lond Engl). 2011;7(5):537-43.
  17. Grynberg M., Gervaise A., Faivre E., Deffieux X., Frydman R., Fernandez H. Management of 22 patients with complete septate uterus: hysterosocopic resection and obstetrical outcome. J Minim Invasive Gynecol 2012;19(1):34-9.
  18. Fanchin R, Frydman N, Even M, Berwanger da Silva AL, Grynberg M, Ayoubi JM. Androgens and poor responders: are we ready to take the plunge into clinical therapy? Fertil Steril. 2011;96(5):1062-5.
  19. Gallot V, Berwanger da Silva AL, Genro V, Grynberg M, Frydman N, Fanchin R. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome. Hum Reprod. 2012;27(4):1066-72.
  20. Grynberg M, Hesters L, Thubert T, Izard V, Fanchin R, Frydman R, Frydman N. Oocyte cryopreservation following failed testicular sperm extraction: a French case report with implications for the management of non-obstructive azoospermia. Reprod Biomed Online. 2012;24(6):611-3.
  21. Grynberg M, Poulain M, Sebag-Peyrelevade S, le Parco S, Fanchin R, Frydman N. Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil Steril. 2012;97(6):1260-8.
  22. Grynberg M, Pierre A, Rey R, Leclerc A, Arouche N, Hesters L, Catteau-Jonard S, Frydman R, Picard JY, Fanchin R, Veitia R, di Clemente N, Taieb J. Differential Regulation of Ovarian Anti-Mullerian Hormone (AMH) by Estradiol through α- and β- Estrogen Receptors. J Clin Endocrinol Metab. 2012;97(9):E1649-57.
  23. Grynberg M, Thubert T, Guilbaud L, Cordier AG, Nedellec S, Lamazou F, Deffieux X. Students’ views on the impact of two pedagogical tools for the teaching of breast and pelvic examination techniques (video-clip and training model): a comparative study. Eur J Obstet Gynecol Reprod Biol. 2012;164(2):205-10.
  24. Berwanger AL, Finet A, El Hachem H, le Parco S, Hesters L, Grynberg M. New trends in female fertility preservation: in vitro maturation of oocytes. Future Oncol. 2012;8(12):1567-73.
  25. Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N. Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum Reprod. 2013 Jan 14.
  26. Grynberg M, El Hachem H, de Bantel A, Benard J, le Parco S, Fanchin R. In vitro maturation of oocytes: uncommon indications. Fertil Steril. 2013;99(5):1182-8.
  27. Grynberg M, Peltoketo H, Christin-Maître S, Poulain M, Bouchard P, Fanchin R. First birth achieved after in vitro maturation of oocytes from a woman endowed with multiple antral follicles unresponsive to follicle-stimulating hormone. J Clin Endocrinol Metab. 2013;98(11):4493-8.
  28. El Hachem H., Poulain M., Finet A., Le Parco S., Fanchin R., Grynberg M. Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro. Gynecol Endocrinol. 2014;30(6):415-8.
  29. Poulain M, Hesters L, Sanglier T, Fanchin R, Frydman N, Grynberg M. At which stage should human embryos be included in research programs? Reprod Biomed Online. 2014;28(4):522-9.
  30. Foix-L’Hélias L, Grynberg M, Ducot B, Frydman N, Kerbrat V, Bouyer J, Labrune P. Are the outcomes of French IVM children different from those of children born after ICSI ? PLOS One. 2014 26;9(2):e89713. doi: 10.1371/journal.pone.0089713. eCollection 2014.
  31. Trèves R, Grynberg M, Le Parco S, Hesters L, Fanchin R. The envisioning of a future life offered by FP helps patients to cope with the burden of cancer treatment. Future Oncol. 2014;10(6):969-74.
  32. Sifer C, El Khattabi L, Dupont C, Sermondade N, Herbemont C, Porcher R, Cedrin-Durnerin I, Faure C, Lévy R, Grynberg M, Poncelet C, Hugues JN. Could sperm grade under high magnification condition predict IMSI clinical outcome? Eur J Obstet Gynecol Reprod Biol. 2014;181:189-94.
  33. Sifer C, Herbemont C, Adda-Herzog E, Sermondade N, Dupont C, Cedrin-Durnerin I, Poncelet C, Levy R, Grynberg M, Hugues JN. Clinical predictive criteria associated with live birth following elective single embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2014;181:229-32.
  34. Grynberg M, Frydman R. Surgical strategies of fertility preservation in female cancers. Minerva Ginecol. 2014;66(5):421-30.
  35. El Hachem H, Atallah D, Grynberg M. Fertility preservation in breast cancer patients. Future Oncol. 2014;10(10):1767-77.
  36. El Hachem H, Poulain M, Höher M, Fanchin R, Frydman R, Grynberg M. Serous adenocarcinoma of the ovary diagnosed during ultrasound evaluation for fertility. Future Oncol. 2014;10(12):1907-12.
  37. Grynberg M. A plea for female fertility preservation. Future Oncol. 2014;10(14):2107-10.
  38. Dupont C, Hafhouf E, Sermondade N, Sellam O, Herbemont C, Boujenah J, Faure C, Levy R, Poncelet C, Hugues JN, Cedrin-Durnerin I, Sonigo C, Grynberg M, Sifer C. Delivery rates after elective single cryopreserved embryo transfer related to embryo survival. Eur J Obstet Gynecol Reprod Biol. 2015;188:6-11.
  39. Sonigo C, Sermondade N, Benard J, Benoit A, Shore J, Sifer C, Grynberg M. The past, present and future of fertility preservation in cancer patients. Future Oncol. 2015 Sep 11.
  40. Frydman R, Grynberg M. Introduction: Female fertility preservation: innovations and questions. Fertil Steril. 2016;105(1):4-5.
  41. Grynberg M, Bidet M, Benard J, Poulain M, Sonigo C, Cédrin-Durnerin I, Polak M. Fertility preservation in Turner syndrome. Fertil Steril. 2016;105(1):13-9.
  42. Frydman R, Grynberg M. Introduction: Male fertility preservation: innovations and questions. Fertil Steril. 2016;105(2):247-8.
  43. Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Hum Reprod. 2016;31(3):623-9.
  44. Sonigo C, Seroka A, Cédrin-Durnerin I, Sermondade N, Sifer C, Grynberg M. History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates. Future Oncol. 2016 Mar 10.
  45. Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, Grynberg M. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? Hum Reprod. 2016;31(7):1493-500.
  46. Bénard J, Duros S, El Hachem H, Sonigo C, Sifer C, Grynberg M. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art. Future Oncol. 2016;12(14):1731-41.
  47. Grynberg M. The challenge of fertility preservation in cancer patients: a special focus issue from Future Oncology. Future Oncol. 2016;12(14):1667-9.
  48. Sifer C, Sellam-Chokron O, Sermondade N, Cedrin-Durnerin I, Sonigo C, Herbemont C, Grynberg M. Should metaphase 1 and 2 stages oocytes be vitrified in the same time for fertility preservation? Future Oncol. 2016 Jul 12.
  49. Grynberg M, Parker J, Dennis-Beron S. The challenge of fertility preservation in cancer patients II: a themed issue of Future Oncology. Future Oncol. 2016 Oct;12(20):2291-2.
  50. Sonigo C, Sermondade N, Grynberg M. Letter in reply to “Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations”. Future Oncol. 2016 Dec 8.
  51. Carde PP, Grynberg M, Poirot C, Glimelius B, Mounier N. Reply to C.F. Hess et al. J Clin Oncol. 2017 Jan 20;35(3):374.
  52. Scheffer JB, Scheffer BB, de Carvalho RF, Rodrigues J, Grynberg M, Mendez Lozano DH. Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response. Int J Fertil Steril. 2017 Apr-Jun;11(1):40-46.
  53. Hugon-Rodin J, Sonigo C, Gompel A, Dodé C, Grynberg M, Binart N, Beau I. First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome. BMC Med Genet. 2017 Apr 26;18(1):44
  54. Herbemont C, Sarandi S, Boujenah J, Cedrin-Durnerin I, Sermondade N, Vivot A,  Poncelet C, Grynberg M, Sifer C. Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality? Reprod Biomed Online. 2017 Nov;35(5):521-528.
  55. Pierre A, Taieb J, Giton F, Grynberg M, Touleimat S, El Hachem H, Fanchin R, Monniaux D, Cohen-Tannoudji J, di Clemente N, Racine C. Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017 Nov 1;102(11):3970-3978.
  56. Sonigo C, Comtet M, Duros S, Sifer C, Sermondade N, Grynberg M. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin’s lymphoma when compared with breast cancer candidates for fertility preservation. J Assist Reprod Genet. 2018 Jan;35(1):91-97.
  57. Raad J, Sonigo C, Tran C, Sifer C, Durnerin IC, Grynberg M. Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study… and many unresolved questions. Letter to the Editor. Eur J Obstet Gynecol Reprod Biol. 2018 Jan;220:140-141.
  58. Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C. Fertility preservation in BRCA-mutated women: when and how? Future Oncol. 2018.
  59. Grynberg M, Sonigo C, Santulli P. Fertility Preservation in Women. N Engl J Med. 2018 Jan 25;378(4):400.
  60. Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation. Fertil Steril. 2018 Dec 6.
  61. El Hachem H, Sonigo C, Benard J, Presse M, Sifer C, Sermondade N, Grynberg M. Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation. PLoS One. 2018 Dec 6;13(12):e0208576.
  62. Herbemont C, Chekroune S, Bonan S, Cedrin-Durnerin I, Vivot A, Sonigo C, Boujenah J, Grynberg M, Sifer C. Impact of post-warming culture duration on clinical outcomes of vitrified good-quality blastocyst transfers: a prospective randomized study. Fertil Steril. 2018 Dec;110(7):1290-1297.
  63. Grynberg M, Murphy C, Doré C, Fresneau L, Paillet S, Petrica N, Frédérique M, Ravonimbola H. A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction program from a French perspective. J Med Econ. 2018 Nov 21:1-15.
  64. Papanikolaou EG, Timotheou E, Tatsi P, Janssens H, Grynberg M, Athanasiadis A, Zafeirati C, Najdecki R, Petousis S. COMFFETI, Combined Fresh and Frozen Embryo Transfers per Individual: A New Index of Quality Control for The Performance of emberyologic Labs in The Emerging Era of Segmentation of Cycle and Freeze-All Strategy. Int J Fertil Steril. 2019 Jan;12(4):339-342.
  65. Pistilli B, Mazouni C, Zingarello A, Faron M, Saghatchian M, Grynberg M, Spielmann M, Kerbrat P, Roché H, Lorgis V, Bachelot T, Campone M, Levy C, Gonçalves A, Lesur A, Veyret C, Vanlemmens L, Lemonnier J, Delaloge S. Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials. Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30264-7.
  66. Sonigo C, Jankowski S, Yoo O, Trassard O, Bousquet N, Grynberg M, Beau I, Binart N. High-throughput ovarian follicle counting by an innovative deep learning approach. Sci Rep. 2018 Sep 10;8(1):13499.
  67. Sonigo C, Beau I, Grynberg M, Binart N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J. 2018 Aug 16:fj201801089R.
  68. Scheffer JAB, Scheffer B, Scheffer R, Florencio F, Grynberg M, Lozano DM. Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF? JBRA Assist Reprod. 2018 Sep 1;22(3):215-220.
  69. Bénard J, Sermondade N, Grynberg M. Fertility Preservation in Endocrine Disorders during Transition for Girls. Endocr Dev. 2018;33:128-148.
  70. Vinolas C, Raad J, Sonigo C, Sifer C, Sermondade N, Grynberg M. Medical techniques of fertility preservation in the male and female. J Visc Surg. 2018 Jun;155 Suppl 1:S3-S9.
  71. Papanikolaou EG, Yarali H, Timotheou E, Grynberg M, Zafeiratis O, Tournaye H, Najdecki R. A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol. Front Endocrinol (Lausanne). 2018 Mar 1;9:25.
  72. Grynberg M. The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg. Future Oncol. 2018 Mar;14(6):497-498.
  73. Sonigo C, Beau I, Binart N, Grynberg M. Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications. Clin Med Insights Reprod Health. 2019 Jun 14;13:1179558119854755.
  74. Stoeklé HC, Bollet M, Cobat A, Charlier P, Bloch OC, Flatot J, Draghi C, Tolyan V, Hervé C, Desvaux P, Uzan L, Grynberg M, Alcaïs A, Tolédano A, Vogt G. French-style genetics v. 2.0: The “e-CohortE” project. Clin Genet. 2019 Oct;96(4):330-340.
  75. Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Daraï E, Chabbert-Buffet N, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, Thibault MR, Ferron G, Devouassoux M, Kurtz JE, Provansal M, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers. Eur J Cancer. 2019 Jul;116:35-44.
  76. Grynberg M, Labrosse J. Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria. Front Endocrinol (Lausanne). 2019 Apr 16;10:246.
  77. Scheffer JB, Scheffer BB, Carvalho RF, Aguiar AP, Lozano DHM, Labrosse J, Grynberg M. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol. JBRA Assist Reprod. 2019 Aug 22;23(3):239-245.
  78. Cédrin-Durnerin I, Isnard T, Mahdjoub S, Sonigo C, Seroka A, Comtet M, Herbemont C, Sifer C, Grynberg M. Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium. Reprod Biomed Online. 2019 Mar;38(3):472-480.
  79. Grynberg M, Dagher Hayeck B, Papanikolaou EG, Sifer C, Sermondade N, Sonigo C. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. Hum Reprod. 2018 Dec 17.

B.Publications in French in peer-reviewed journals

  1. Grynberg M, Dedecker F, Staerman F. Laparoscopic sacral colpopexy: comparaison of nonresorbable prosthetic type‚ Mersuture®) and SIS collagen matrix SIS (Surgisis®ES). Prog Urol. 2005;15(4):751-755.
  2. Dedecker F, Grynberg M,  Staerman F. Small intestinal submucosa (SIS): prospects in urogenital surgery. Prog Urol. 2005;15(3):405-10.
  3. Grynberg M, O. Graesslin, J. Teyssedre, P. Birembaut, C. Quereux. Multiple recurrent papillomas of the breast : a case report. Gynecologie Obstétrique et Fertilité 2007;35(2):125-8.
  4. Salama S., Grynberg M., Lamazou F., Frydman N., Frydman R., Fanchin R. Assisted reproductive technology: biological, medical and ethical aspects. Rev Prat. 2008;58(3):319-25.
  5. Lamazou F, Letouzey V, Arbo E, Grynberg M, Levaillant JM, Frydman R, Fanchin R.    The role of ultrasound examination to evaluate ovarian reserve of infertile patients. Gynecol Obstet Fertil. 2009;37(5):425-431.
  6. Grynberg M, Roux I, Frydman R. Assistance médicale à la procréation et filiation. Encyclopédie Médico-Chirurgicale Gynécologie, 2010. 
  7. Grynberg M, Hesters L, Gallot V, Fernandez H. Préservation de la fertilité féminine et cancer. Encyclopédie Médico-Chirurgicale Gynécologie, 2010.
  8. Gallot V, Even M, Berwanger Da Silva AL, Grynberg M, Lamazou F, Fanchin R. Against performing homologous intrauterine insemination beyond 35 years of age. Gynecol Obstet Fertil. 2010 Apr 5. 
  9. da Silva AL, Even M, Grynberg M, Gallot V, Frydman R, Fanchin R. Anti-Müllerian hormone: player and marker of folliculogenesis. Gynecol Obstet Fertil. 2010;38(7-8):471-4.
  10. Basille C, Torre A, Grynberg M, Gallot V, Frydman R, Fanchin R. Statement: cancer treatments and ovarian reserve. J Gynecol Obstet Biol Reprod (Paris). 2010;39(6):433-43.
  11. Grynberg M, Chevalier N, Mesner A, Rocher L, Prisant N, Madoux S, Feyereisen E, Ferlicot S, Fanchin R, Frydman R, Frydman N, Izard V. Non-obstuctive azoospermia: Option of the testicular sperm extraction performed on the day of oocyte retrieval. J Gynecol Obstet Biol Reprod (Paris). 2010 Dec 21.
  12. Grynberg M, Hesters L, Benard J, Trèves R, Fanchin R, Frydman R, Frydman N. In vitro maturation of oocytes: An option for fertility preservation in women. J Gynecol Obstet Biol Reprod (Paris). 2011 Jan 11.
  13. Lamazou F, Genro V, Fuchs F, Grynberg M, Gallot V, Achour-Frydman N, Fanchin R, Frydman R. Serum AMH level is not a predictive value for IVF in modified natural cycle: Analysis of 342 cycles. J Gynecol Obstet Biol Reprod (Paris).
  14. Le Gouez A, Naudin B, Grynberg M, Mercier FJ. Ovarian hyperstimulation syndrome. Ann Fr Anesth Reanim. 2011 Mar 11.
  15. Trèves R, Grynberg M, Hesters L, Fanchin R, Frydman R. Fertility preservation in cancer women: A multidisciplinary approach. J Gynecol Obstet Biol Reprod (Paris). 2011 Jun 30.
  16. Lamazou F, Fuchs F, Grynberg M, Gallot V, Herzog E, Fanchin R, Frydman N, Frydman R. Cancellation of IVF-ET cycles: Poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimualtion? An analysis of 142 cancellations. J Gynecol Obstet Biol Reprod (Paris). 2011 Aug 9.
  17. Lamazou F, Legouez A, Letouzey V, Grynberg M, Deffieux X, Trichot C, Fernandez H, Frydman R. Ovarian hyperstimulation syndrome: Pathophysiology, risk factors, prevention, diagnosis and treatment. J Gynecol Obstet Biol Reprod (Paris). 2011 Aug 9.
  18. Toledano M, Lamazou F, Gallot V, Frydman R, Fanchin R, Grynberg M. Are mild ovarian stimulations for IVF-ET a significant progress in assisted reproductive technologies?. J Gynecol Obstet Biol Reprod (Paris). 2012;41(1):6-13.
  19. Grynberg M, Even M, Berwanger da Silva AL, Gallot V, Toledano M, Frydman R, Fanchin R. Cancer, fertility preservation and gonadotropins. J Gynecol Obstet Biol Reprod (Paris). 2012 May 24.
  20. Grynberg M, Thubert T, Hesters L, Frydman R, Frydman N, Izard V. Regarding the French legislation regulating assisted reproduction technologies: Will oocyte cryopreservation impact on the timing of the testicular biopsy in patients suffering from non obstructive azoospermia?. Prog Urol. 2012;22(9):553-4.
  21. Grynberg M, Poulain M, Le Parco S, Sebag-Peyrelevade S, Frydman N, Benachi A. How to preserve female fertility before cancer treatments? Rev Prat. 2013;63(3):314-8.
  22. Seroka-Vanhove A, Sonigo C, Roche C, Grynberg M. [What’s new in 2014 about anti-Müllerian hormone?]. J Gynecol Obstet Biol Reprod (Paris). 2014;43(8):559-71.
  23. Boujenah J, Bricou A, Moreaux G, Grynberg M, Sifer C, Hugues JN, Poncelet C. [Unilateral borderline ovarian tumor and unilateral adenexectomy?]. Gynecol Obstet Fertil. 2014;42(9):635-9.
  24. Sonigo C, Grynberg M. [In vitro oocyte maturation for female fertility preservation]. Gynecol Obstet Fertil. 2014;42(9):657-60.
  25. Comtet M, Sonigo C, Valdelièvre C, Sermondade N, Sifer C, Grynberg M. [Fertility preservation in breast cancer patients: the state of art in 2014?]. Bull Cancer. 2015;102(5):443-53.
  26. Grynberg M, Benard J. [Fertility preservation and endometriosis: When medical borders on social]. Gynecol Obstet Fertil. 2015;43(12):759-60.
  27. Durand M, Sermondade N, Herbemont C, Benard J, Gronier H, Boujenah J, Cédrin-Durnerin I, Poncelet C, Grynberg M, Sifer C. [Embryo development in two single-step media: Analysis of 2059 sibling oocytes]. Gynecol Obstet Fertil. 2016;44(3):163-7.
  28. Valdelièvre C, Sonigo C, Comtet M, Simon C, Eskenazi S, Grynberg M. [Impact of gonadotropins in women suffering from cancer]. Bull Cancer. 2016;103(3):282-8.
  29. Sarandi S, Herbemont C, Sermondade N, Benoit A, Sonigo C, Poncelet C, Benard J, Gronier H, Boujenah J, Grynberg M, Sifer C. [A prospective study to compare the efficiency of oocyte vitrification using closed or open devices]. Gynecol Obstet Fertil. 2016 Mar 8. pii: S1297-9589(16)30003-0.
  30. Bénard J, Calvo J, Comtet M, Benoit A, Sifer C, Grynberg M. [Fertility preservation in women of the childbearing age: Indications and strategies]. J Gynecol Obstet Biol Reprod (Paris). 2016 Mar 22. pii: S0368-2315(16)00047-8.
  31. Gronier H, Sonigo C, Bringer S, Cedrin-Durnerin I, Hugues JN, Grynberg M. Does accumulation of oocytes benefit to women with poor ovarian reserve? No. Gynecol Obstet Fertil Senol. 2017 Mar;45(3):183-184.
  32. Hugon-Rodin J, Sonigo C, Drummond D, Grynberg M, Rodin T, Plu-Bureau G, Tesniere A. [Learning the gynecological examination on low-fidelity simulation: Impact on the feelings of medical students]. Gynecol Obstet Fertil Senol. 2017 May;45(5):291-298.
  33. Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. Bull Cancer. 2018 Mar;105(3):299-314.

Other publications
A.Publications in French in peer-reviewed journals (non-exhaustive list)

  • Grynberg M., Durier M., Gabriel R. Thrombopenie anomalies de l’hémostase au cours de la grossesse. Réalités en Gynécologie-obstétrique. N° 112. 2006, Juin.
  • Alby C., Grynberg M., Fay S., Frydman R., Fanchin R. IVF-ET problems and results in endometriosic patients. Mt/médecine de la reproduction 2007; 9 (1) : 1-9.
  • Lamazou F., Grynberg M., Fanchin R.Evaluation du statut folliculaire ovarien. Réalités en gynécologie-obstétrique. N°133, Oct 2008. 
  • Grynberg M. Stimulations douces Gynécologie Obstétrique Pratique, 2009
  • Even M, Berwanger da Silva AL, Grynberg M, Hoher M, Gallot V, Fanchin R. Androgènes : l’autre façon de stimuler des follicules ovariens ?
 MT médecine de la reproduction, gynécologie et endocrinologie : Vol.12, n°4, 2010
  • Meryl Toledano, Grynberg MStimulations douces et cycles spontanés Gynécologie Obstétrique Pratique, 2010
  • Grynberg M, Izard V, Frydman R. Assistance médicale à la procréation en situation de handicap Réadaptation 2010. – 572, p. 13-15
  • Grynberg M, Le Parco S Fertilité et cancer du sein: Maturation ovocytaire in vitro Cancers au féminin n° 3/2011
  • Grynberg M, Berwanger AL, Hesters L, Trèves R, Frydman N, Fanchin R. In vitro maturation of oocytes for fertility préservation on breast cancer patients International Journal Breast Disease Centers, January 2012, Issue 1
  • Grynberg M, Even M Maturation ovocytaire in vitro : place dans la stratégie de préservation de la fertilité. MT médecine de la reproduction, gynécologie et endocrinologie : Vol. 14, n°2, 2012
  • Even M, Grynberg M Androgènes et croissance folliculaire. MT médecine de la reproduction, gynécologie et endocrinologie : Vol. 14, n°3, 2012
  • Grynberg M Comment stimuler les patientes en AMP après un cancer ?, Cancers au féminin, 2012, n°3
  • Grynberg M, Le Parco S Préservation de la fertilité féminine avant traitement gonadotoxique., ONKO +, 2013
  • Grynberg M. Résultats de l’AMP chez la femme guérie de  cancer Gynécologie Obstétrique Pratique, 2013
  • Grynberg M. Préservation de la fertilité : une organisation nationale à proposer Gynécologie Obstétrique Pratique, 2013
  • di Clémente N., Seroka A., Sonigo C., Pierre A., Taieb J., Grynberg M. L’hormone anti-müllérienne : nouveautés physiologiques et expérimentales chez la femme.    Médecine Thérapeutique / Médecine de la Reproduction 2014.
  • Benard J, Grynberg M. Physiologie ovarienne. EMC Gynécologie [43123] 2015.
  • Grynberg M.  Techniques de préservation de la fertilité. Dossier site internet de l’INSERM.
  • Grynberg MTechniques d’Assistance Médicale à la Procréation. Dossier site internet de l’INSERM.
  • Calvo J., Sonigo C., Grynberg MPréservation de la fertilité dans le cancer du sein. La Lettre du Cancérologue / N° 4 avril 2016
  • Seroka A., Sonigo C., Grynberg M. Fertilité et préservation de la fertilité en cancérologie digestive. La Lettre de l’Hépato-gastroentérologue / N° 6 décembre 2016
  • Comtet M. Benard J., Grynberg MPréservation de la fertilité féminine EMC Gynécologie [755-A-22] 2016

B.Drafting books coordination

Michaël Grynberg, René Frydman

Préservation de la Fertilité,  Editions Eska, 2012.

Michael Grynberg

Tout-en-un ECN, Gynécologie-Obstétrique, Collection ESTEM, 2015

Florie Pirot, Michaël Grynberg

Les dossiers ECNi, Gynécologie obstétrique, Collection ESTEM, 2015

C.Scientific books in English

  1. Anti-Müllerian hormone : insights into a novel biomarker of the ovarian follicular status. Grynberg M., Feyereisen E., Ferretti C., Frydman R., Fanchin R. ‘Advances in ART and Infertility Management’ Editors: Sulbha Arora, Rubina Merchant,Gautam N Allahbadia
  2. Fertility preservation in endocrine disorders during transition. Benard J., Grynberg MTransition of Care from Childhood to Adulthood in Endocrinology, Gynecology and Diabetology Ed. Karger, 2017
  3. Male and Female Fertility Preservation, Editors M. Grynberg & P. Patrizio, Springer (à paraitre)

D. Scientific books in French

  1. Infections et Grossesse : Bactériologie, « Traité d’Obstétrique », Masson Grynberg M., Durier M., Gabriel R.
  2. Syndrome d’hyperstimulation ovarienne. Guide pratique des urgences chirurgicales: gynécologie-obstétrique: édition Masson: parution en novembre 2008
  3. Grynberg M. Evaluation du statut folliculaire ovarien Physiologie, Pathologie et Thérapie de la Reproduction chez l’Humain Ed. Springer Grynberg M., Fanchin R.
  4. Gonadotrophines et cancer La stimulation ovarienne au quotidien : concepts & astuces Ed Med’Com Grynberg M.
  5. Stimulations ovariennes et préservation de la fertilité Toledano M., Gayet V, Bloquet B, Grynberg M, de Ziegler D. Préservation de la fertilité Ed. Eska
  6. Maturation ovocytaire in vitro : place dans la stratégie de préservation de fertilité Grynberg M, El-Hachem H Préservation de la fertilité Ed. Eska
  7. Préservation de la fertilité et cancer du sein Grynberg M, Sebag-Peyrelevade S Préservation de la fertilité Ed. Eska
  8. Physiologie ovarienne Catteau-Jonard S, Robin G, Grynberg M, Dewailly D Préservation de la fertilité Ed. Eska
  9. Les 100 mots de la maternité. Muriel Flis Treves Presses Universitaires de France (2014)
  10. Benard J, Grynberg MPhysiologie ovarienne. EMC Gynécologie [43123] 2015.
  11. Préservation de la fertilité Grynberg M. Infertilité : prise en charge globale et thérapeutique Ed. Masson, 2016
  12. Comtet M. Benard J., Grynberg MPréservation de la fertilité féminine EMC Gynécologie [755-A-22] 2016
  13. Calvo J., Sonigo C., Grynberg MPréservation de la fertilité dans le cancer du sein La Lettre du Cancérologue / N° 4 avril 2016
  14. Seroka A., Sonigo C., Grynberg MFertilité et préservation de la fertilité en cancérologie digestive La Lettre de l’Hépato-gastroentérologue / N° 6 décembre 2016
  15. Comtet M. Benard J., Grynberg MPréservation de la fertilité féminine EMC Gynécologie [755-A-22] 2016